367 related articles for article (PubMed ID: 23406994)
1. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
[TBL] [Abstract][Full Text] [Related]
2. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
Mantovani G
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):292-301. PubMed ID: 20496538
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
Mantovani G; Macciò A; Madeddu C; Serpe R; Massa E; Dessì M; Panzone F; Contu P
Oncologist; 2010; 15(2):200-11. PubMed ID: 20156909
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.
Madeddu C; Dessì M; Panzone F; Serpe R; Antoni G; Cau MC; Montaldo L; Mela Q; Mura M; Astara G; Tanca FM; Macciò A; Mantovani G
Clin Nutr; 2012 Apr; 31(2):176-82. PubMed ID: 22047681
[TBL] [Abstract][Full Text] [Related]
5. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
[TBL] [Abstract][Full Text] [Related]
6. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].
Herrejón A; Palop J; Inchaurraga I; López A; Bañuls C; Hernández A; Blanquer R; Están N; Anguera A
Med Clin (Barc); 2011 Jul; 137(5):193-8. PubMed ID: 21524765
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
[TBL] [Abstract][Full Text] [Related]
8. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
[TBL] [Abstract][Full Text] [Related]
9. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.
Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Sanna E; Cau MC; Panzone F; Mantovani G
Gynecol Oncol; 2012 Mar; 124(3):417-25. PubMed ID: 22198049
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
12. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
13. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.
Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I
Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631
[TBL] [Abstract][Full Text] [Related]
14. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
[TBL] [Abstract][Full Text] [Related]
15. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
[TBL] [Abstract][Full Text] [Related]
16. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
Yeh SS; Lovitt S; Schuster MW
J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752
[TBL] [Abstract][Full Text] [Related]
17. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
Berenstein EG; Ortiz Z
Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
[TBL] [Abstract][Full Text] [Related]
18. Megestrol acetate for treatment of anorexia-cachexia syndrome.
Ruiz Garcia V; López-Briz E; Carbonell Sanchis R; Gonzalvez Perales JL; Bort-Marti S
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD004310. PubMed ID: 23543530
[TBL] [Abstract][Full Text] [Related]
19. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V; Testa A; Gebbia N
Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
